The brain's glymphatic system serves as a critical waste-clearance pathway. Recent evidence highlights how this mechanism fails in patients with chronic hypercortisolism. Specifically, glymphatic function in Cushing's disease appears significantly reduced. This impairment contributes directly to the white matter damage frequently observed in these patients. Researchers have now identified that the glymphatic system acts as a mediator between hormonal imbalance and structural brain injury.

Patients with Cushing's disease (CD) often suffer from cognitive impairment and mood disorders. Although white matter microstructural injury is a known feature of the disease, the underlying causes were previously unclear. This study analyzed 69 patients with CD and 64 healthy controls to investigate the connection. Using advanced neuroimaging, the team found that CD patients exhibit a significantly lower DTI-ALPS index, which is a key marker of glymphatic efficiency.

Impact of Glymphatic Function in Cushing's on White Matter

The research demonstrated widespread white matter injury in CD patients. This damage was characterized by decreased fractional anisotropy (FA) in 25 different tracts. Notably, the study focused on the right superior longitudinal fasciculus III (SLF IIIR). The SLF IIIR is essential for visuospatial processing and attention. Analysis showed that lower glymphatic flow directly correlates with the severity of damage in this specific tract. Consequently, the failure of the brain's "drainage system" leaves white matter vulnerable to degradation.

Furthermore, the study explored the biochemical drivers of this dysfunction. Serum cortisol levels, particularly those measured at midnight (00:00), showed a strong negative correlation with the DTI-ALPS index. This suggests that the loss of the normal cortisol circadian rhythm is a primary cause of glymphatic failure. High nocturnal cortisol levels likely suppress the glymphatic system, which is typically most active during rest.

The Role of Midnight Cortisol

Mediation analysis provided a breakthrough in understanding the disease progression. It confirmed that glymphatic impairment fully mediates the effect of midnight cortisol on white matter. Essentially, high cortisol levels do not damage the SLF IIIR directly. Instead, they disable the glymphatic system first. The resulting buildup of metabolic waste then causes microstructural injury to the nerve fibers. Therefore, controlling midnight cortisol levels is vital for preserving brain health in CD patients.

These findings offer a new perspective for endocrinologists and neurologists. They suggest that glymphatic function in Cushing's could be a therapeutic target. Improving glymphatic clearance might help mitigate the long-term cognitive effects of hypercortisolism. Monitoring the DTI-ALPS index may also provide a non-invasive way to track brain health during treatment.

How is the glymphatic system measured in this study?

Researchers used the DTI-ALPS index, an MRI-based metric. It calculates the ratio of water diffusion along perivascular spaces. A lower index indicates reduced glymphatic flow and poorer waste clearance in the brain.

Why is the SLF IIIR tract specifically mentioned?

The right superior longitudinal fasciculus III (SLF IIIR) showed the most significant correlation with glymphatic dysfunction. Damage to this tract is linked to the visuospatial and attention deficits often seen in Cushing's disease patients.

Can glymphatic function be restored?

While the study focuses on the mechanism of injury, it suggests that normalizing cortisol levels may help. Restoring the circadian rhythm of cortisol is likely key to regaining glymphatic efficiency and protecting white matter.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.

References

Sun Y et al. Association Between Glymphatic Function and White Matter Microstructural Injury in Patients With Cushing's Disease. Brain Behav. 2026 Mar undefined. doi: 10.1002/brb3.71285. PMID: 41764040.

Taoka T, et al. Evaluation of glymphatic system function with diffusion junction analysis along the perivascular space (DTI-ALPS). Jpn J Radiol. 2022;40(6):551-564.

Li Y, et al. Glymphatic dysfunction associated with cortisol dysregulation in major depressive disorder. J Affect Disord. 2024;347:332-340.